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Viruses are dependent biological entities that interact with the genetic material of most cells on the planet,
including the trillions within the human microbiome. Their tremendous diversity renders analysis of human
viral communities (“viromes”) to be highly complex. Because many of the viruses in humans are
bacteriophage, their dynamic interactions with their cellular hosts add greatly to the complexities observed
in examining human microbial ecosystems. We are only beginning to be able to study human viral
communities on a large scale, mostly as a result of recent and continued advancements in sequencing and
bioinformatic technologies. Bacteriophage community diversity in humans not only is inexorably linked to the
diversity of their cellular hosts but also is due to their rapid evolution, horizontal gene transfers, and intimate
interactions with host nucleic acids. There are vast numbers of observed viral genotypes on many body
surfaces studied, including the oral, gastrointestinal, and respiratory tracts, and even in the human
bloodstream, which previously was considered a purely sterile environment. The presence of viruses in blood
suggests that virome members can traverse mucosal barriers, as indeed these communities are substantially
altered when mucosal defenses are weakened. Perhaps the most interesting aspect of human viral
communities is the extent to which they can carry gene functions involved in the pathogenesis of their hosts,
particularly antibiotic resistance. Persons in close contact with each other have been shown to share a fraction
of oral virobiota, which could potentially have important implications for the spread of antibiotic resistance to
healthy individuals. Because viruses can have a large impact on ecosystem dynamics through mechanisms
such as the transfers of beneficial gene functions or the lysis of certain populations of cellular hosts, they may
have both beneficial and detrimental roles that affect human health, including improvements in microbial
resilience to disturbances, immune evasion, maintenance of physiologic processes, and altering the microbial
community in ways that promote or prevent pathogen colonization.
© 2014 Elsevier Ltd. All rights reserved.Introduction
Microorganisms and their viruses inhabit every
surface of the human body and are recently widely
recognized to be a major factor shaping human
health. Cellular microbes, including bacteria, archaea,
and fungi colonizing human body surfaces, outnum-
ber human host cells by approximately 10 is to 1 and
play crucial roles in human health by several means
including contributions to nutrition, inflammation, and
immunity [1–4]. Bacteria are the most populous
cellular microbes inhabiting body surfaces, and theirer Ltd. All rights reserved.viruses (bacteriophage) are significantly more preva-
lent in humans than their eukaryotic counterparts [5,6].
There is now increased interest and research on the
community of viruses (virobiota) and bacteria (micro-
biota) afforded by the advances in next-generation
sequencing technologies and analysis tools that have
improvedour capabilities in the field ofmetagenomics.
Recognizing the complexity and diversity within these
dynamic viral communities has given new perspective
on the human body as an ecosystem, reestablishing
the role of microbes in human health and disease at
the start of the 21st century.J. Mol. Biol. (2014) 426, 3892–3906
3893Review: Role of Viruses in MicrobiomesViruses are parasitic biologic entities that require
host cells for replication. They are made up of single-
or double-stranded DNA or RNA and a protein
capsid, which form a structure called a virion. Some
viruses may also have a lipid envelope modified from
their host cell membrane. They are considered
ubiquitous in that they infect nearly every type of
cell (including eukaryotes, bacteria, archaea, and
fungi) and are found in every ecosystem previously
described [7]. Despite the large presence of phage
on the planet, they were not discovered until 1915
due to their predominantly sub-microscopic exis-
tence. To this day, we remain in an age of viral
discovery; most of the viruses currently being
described using deep sequencing methods have
not been described before and have no homologous
sequences in current virus sequence databases
[6,8,9]. Equally important to the next-generation
sequencing are advancements in informatics allow-
ing us to make more meaningful analyses of
viromes. Tools such as the bioinformatic pipeline
VIROME (Viral Informatics Resource for Metagen-
ome Exploration) and OptItDBA (Optimized Iterative
de Bruijn Graph Assembly) have greatly improved
the breadth and accessibility of virome analysis by
improving assembly and annotating viromes against
multiple annotated sequence databases, which
improves the analytic capabilities beyond the con-
straints of individual sequence databases [10,11].
Some molecular interactions between viruses and
their hosts can be deduced from analysis of
metagenomic data, which add substantially to
knowledge gained from studies of laboratory-a-
dapted host-virus model systems.
While historically many viruses in humans have
been identified based on their direct pathogenic
effects, we now know that there is a vast viral
community in the human body that does not directly
cause human disease. In fact, a large portion of the
viruses identified thus far in the human virome are
bacteriophage rather than eukaryotic viruses [5,6].
We will now review the current data available from
studies of the human virome. Despite the current
limitations in virome analysis such as the lack of
available homologous sequences to identify viral
community constituents, the relative dearth of infor-
mation about RNA viruses in human microbial
communities, and potential methodological limitations
that may limit recovery of eukaryotic viruses, the
continually growing number of studies focusing on
viruses as members of the human microbiome
provide numerous insights into the role and molecular
basis of viral contributions to the human microbiome.Bacteriophage and Bacterial Coevolution
Bacteria and their viruses have coexisted and
coevolved for approximately 3–5 billion years [12]but have been only recently shown to coexist in great
abundance as members of the human microbiome.
For perspective, the origin of mammals traces back
to only 225 million years ago [13]; primates, to about
65 million years ago [14]; andHomo sapiens sapiens
ancestry, to 200,000 years ago. There are an
estimated 1031 phage on earth, based on calcula-
tions of 1030 bacteria on the planet [15] and
approximately 10 phage that exist for every bacteria
[16]. Comparatively, there are only 1022–1024 stars
estimated to exist in the entire universe [17]. Phage
are a component of virtually all molecular commu-
nities described thus far on the planet [18,19]. They
are an important vehicle for exchange of genetic
materials among living organisms and are likely a
means by which gene functions are exchanged in
the human microbiome [20–22].
Phage have been shown to be a major stimulus for
evolutionary change among bacteria [16,23] and thus
are dominant players in shaping the microbiota of all
metazoans. They have classically been regarded as
having high host specificity as an important aspect of
their ecology, as many have been shown to only
parasitize within a certain species and even within a
subset of that species [24–28]. The increased fitness
of phage with high host specificity has been largely
explained by two major observations: (1) decreased
efficiency for infection with broader host range [29]
and (2) antagonistic pleiotropy in which an adaptation
is beneficial for certain hosts but deleterious to others
[30]. However, with such diversity in bacteria commu-
nities, a broader host range could be advantageousby
increasing the chances of a phage encountering a
suitable host cell, particularly in the setting of rare
bacteria [31]. More recently, the classic view of phage
host specificity has been challenged as a potential
artifact from observationsmade on phage selected for
the laboratory setting [7,32]. Instead of specificity
always being advantageous over a more generalist
approach, there likely exists a spectrum of viral
tropism that is dependent on environmental, bacterial,
and phage characteristics [33].
Phage provide great evolutionary pressure on
bacteria, spurring mutations and adaptations and
changing the existing gene pool. In vitro studies of
Pseudomonas fluorescens and its phage have
demonstrated a 10- to 100-fold increase in mutation
rates over 200 bacterial generations compared to
bacteria grown in the absence of phage [34,35].
Although the in vitro scenario of one bacteria
evolving with one phage does not reflect in vivo
evolutionary conditions, coevolution has also been
shown to occur rapidly in an in vivo study using a
“mark-recapture” strategy with P. fluorescens and its
lytic bacteriophage [36]. The demonstration of the
stimulus for evolution importantly demonstrates the
significant impact that communities of phage may
have as members of the human microbiome. In the
setting of increased variables such as competition
3894 Review: Role of Viruses in Microbiomesamong bacterial members and natural fluctuations in
the host and environment, the presence of phage
communities could greatly accelerate genetic evo-
lution in human bacterial communities and poten-
tially lead to major shifts in microbial community
structures.
Phage are major sources of horizontal gene
transfer among various bacterial strains, species,
and even genera [37]. For example, trans-species
horizontal transfer has been shown to occur with
mobile toxin-carrying Staphylococcus aureus path-
ogenicity islands. S. aureus pathogenicity islands
have been shown to transfer across species from
S. aureus to coagulase-negative Staphylococcus
[38] and even outside of the genus to Listeria
monocytogenes [21]. Although there are expected
fitness costs with horizontal gene transfers, they can
occur without detectable losses in fitness [39]. An in
vitro study in which DNA fragments from bacteria or
phage were introduced into a specified position in
the Salmonella chromosome showed that over 80%
of insertions had no apparent impact on bacterial
host fitness [39]. In the analysis of pathogens, there
is evidence that horizontal gene transfers may result
in conferring pathogenic traits and increased
virulence to the bacterial host, such as what has
been shown with increased virulence of Salmonella
typhimurium with horizontal gene transfer via the
SopEΦ phage [40]. Thus phage are powerful agents
of genetic change for bacteria, enriching the genetic
diversity in microbial populations and stimulating
adaptation among bacteria. Given the preponder-
ance of phage inhabiting the human microbiome, the
potential for phage to transfer genes involved in
pathogenicity across bacterial genera has substan-
tial implications for human health.
Bacterial resistance mechanisms for phage
Bacteria have evolved numerous strategies for
resisting their phage at every stage of attack,
encouraging high phage diversity as they respond
to bacterial strategies to avoid predation. The first
step in phage infection involves recognition of
specific host receptors, and bacteria have developed
phage adsorption blocking mechanisms to escape
attack by lytic phage. Some of these adsorption
blocking strategies include the inhibition of phage
binding to its receptor by phase variation of
receptors, production of thick extracellular matrix to
limit access to receptors, and alteration of receptor
binding sites to escape phage attack [41]. Another
common group of strategies of bacterial defenses for
phage include restriction–modification defenses that
involve the degradation of unmodified phage DNA.
This mechanism is believed to be active in about
90% of the bacterial genomes sequenced thus far
[42]. After infection with phage, a subset of bacteria
actually undergo self-destructive pathways (such aswith toxin–antitoxin systems) in what seems to be an
altruistic apoptosis to limit the spread of phage
progeny [41,43]. There may even be ecological or
epigenetic factors that affect a bacteria's resistance
against phage, which may explain the recovery of a
Bacteroides caccae population in gnotobiotic mice
after experimental infection with virus-like particles
(VLPs) in which there was initial bacterial decimation
followed by recovery in the absence of any
detectable bacterial genetic changes [44].
Another anti-phage strategy used in a large subset
of bacteria are CRISPR (clustered regularly inter-
spaced short palindromic repeats) and Cas (CRIS-
PR-associated proteins) (referred to as CRISPR–Cas
systems) in which sections of bacterial DNA that
contain characteristic repeats are able to incorporate
short sequences of viral DNA called “spacers” when
confronted with phage. These intercepted segments
of viral DNA are then able to interfere with phage
genomic replication in future bacterial–phage encoun-
ters [45,46]. There are numerous repertoires of
CRISPR spacers on human body surfaces, suggest-
ing that the indigenousmicrobiota haveCRISPR–Cas
systems that are likely active in acquired resistance
against phage in humans [47–49].
Bacteriophage strategies for countering bacterial
resistance mechanisms
Phage continuously develop counterstrategies to
evade defenses developed by their host bacteria.
They have been observed undergoing point muta-
tions [50,51], horizontal gene transfers [37,52], and
genome rearrangements [53,54] in the laboratory
and in vivo to counter bacterial defenses [55].
Numerous mutations have been shown to allow
phage to escape bacterial strategies of adsorption
inhibition either by being adaptive to new or modified
receptor targets or by accessing receptor targets that
have been protected by bacteria [55]. If phage have
entered a cell with restriction–modification defenses,
phage can resist these systems with mutations that
prevent recognition by restriction endonucleases
and thus escape cleavage [56,57]. Lysogenic
phage that evolve with their host bacteria also take
on similar patterns of nucleotide usage as that of
their hosts and, thus, avoid using the cognate
sequences of host restriction endonucleases [58].
For phage encountering bacteria that undergo
abortive infection such as with toxin–antitoxin
systems, phage adapt by interfering with and
inactivating host cell death [54,59,60]. Recently,
even phage strategies that allow for avoidance of
recognition by or interference with bacterial
CRISPR–Cas systems have been recognized
[61 ,62 ] . Thus th rough adap ta t ions and
counter-adaptations, the multitudes of phage and
bacteria in ecosystems throughout our world and
probably in the human microbiome are constantly
3895Review: Role of Viruses in Microbiomesshifting through evolutionary pressures imposed
upon each other.
Phageprovideevolutionary advantages tobacteria
The evolutionary success of phage not only stems
from overcoming bacterial defenses but also in-
cludes providing selective advantages to their
bacterial hosts [20]. This is particularly true for
lysogenic phage that effectively are symbionts of
bacteria for much of their life cycle, incorporated
inside of the bacterial genome, and dependent on
bacterial binary fission for its own replication [63].
There are multiple ways in which prophage (lyso-
genic phage incorporated into a genome) offer
evolutionary advantages to their hosts through
genetic diversity [64]. Phage may introduce genes
that confer an evolutionary advantage in particular
environmental circumstances, such that if the milieu
changes, bacteria are already present with a fitness
advantage. For example, in the setting of a particular
nutritional milieu, two prophage within Enterococcus
faecalis are induced to form a composite lytic
phage ϕV1/7 that confer an advantage over other
E. faecalis strains as seen in vitro, in the mouse
intestine, and possibly in the human intestine [65].
Genes introduced to bacteria via prophage may offer
protection of host bacteria from infection with other
phage. In phage HK97 among others, superinfection
exclusion has been observed, where the presence
of a prophage containing a particular insertion
excludes superinfection with similar phage [66]. A
notorious way in which phage offer selective
advantages is through the introduction of virulence
factors to their hosts. Lysogenic phage are known to
provide virulence factors to their host cells that can
enhance survival [67–70]. Even lytic phage can
select for more virulent phenotypes, as with selec-
tion for mucoid Pseudomonas in the presence of lytic
phage ϕ2 [71]. In general, phage predation keeps
the density of any single bacterial strain in check,
which may profoundly affect the dynamics within the
human microbiome, allowing for a more diverse
bacterial gene pool that is better adapted to
changing environmental conditions [72,73].
Phage as members of human viromes have been
found to carry gene functions that are putatively
involved in the pathogenesis of their host bacteria. In
the human oral cavity, phage members of the virome
have been found to carry genes involved in resistance
to complement, degradation of immunoglobulins,
adhesion to the cells lining the oropharynx, and
antibiotic resistance [6,74]. In the gastrointestinal
tract, phage carry substantial repertoires of antibiotic
resistance, including β-lactamases, multi-drug trans-
porters, and genes putatively involved in vancomycin
resistance [75]. The fact that phage on human body
surfaces carry genes putatively involved in the
pathogenesis and survival of their hosts suggeststhatmany live in dynamic equilibriumwith their cellular
hosts and adds greatly to the complex dynamics
occurring in the human microbiome.VirusesPlay ImportantRoles asMembers
of the Human Microbiome
Overview of human virome characteristics
Viruses, most of which are bacteriophage, exist in
all surfaces of the human body [6,75]. The viromes of
the human body have high levels of genetic diversity
previously largely unrecognized, now being revealed
with the increased detail afforded by deep sequenc-
ing methods [76,77]. The majority of the viruses
inhabiting the body, as with other environments, lack
homology to viruses present in existing databases
[9,78]. While the identification of phage is limited by
incomplete representation in these databases, the
lack of available homologues does not preclude
analysis of viral community dynamics [10,11].
Virome analysis of the human gut and oral cavity
have revealed that membership in these communi-
ties is highly personalized [6,74,75,79]. Several
studies have established that rather than a single
virus predominating within a body surface's virome,
there are generally numerous genotypes with no
single predominant virus [6,80]. Moreover, contrary
to dynamics that might be observed for simple
predator/prey relationships, many phage are persis-
tent members of the human microbiome [74,79].
There are several factors that are known to affect
the membership of human viral communities. Either
through personal contact or shared environmental
reservoirs, individuals who live together share a
significantly higher proportion of virobiota than would
be expected to occur by chance, as demonstrated in
oral viromes [80,81]. Host sex appears to exert an
influence on virome membership as well [74]. As
most of the viruses identified in that study were
phage, changes in their ecology likely reflect
hormonally driven fluctuations in their host bacterial
communities [82–84]. While these observations
suggest that characteristics observed in phage
populations may reflect trends in their cellular hosts
due to the complex relationships observed between
viruses and their hosts in the human microbiome,
relative abundances of viruses do not necessarily
reflect the relative abundances of their host bacteria
[6].
Viral ecology in the human gut
Many gut phage are predicted to have lysogenic
lifestyles [79,85], but the majority remain unchar-
acterized due to lack of available homologous viral
sequences. The focus of study thus far on the human
3896 Review: Role of Viruses in Microbiomesgut virome has been DNA viruses in feces, the
majority of which have been bacteriophage [86].
Most of these gut viruses have been putatively
classified as double-stranded DNA viruses in the
Caudovirales order (including Podoviridae, Siphovir-
idae, and Myoviridae) or single-stranded DNA
viruses in the Microviridae and Inoviridae families
[78,85]. The concentration of VLPs in the human
feces is estimated to be between 108 and 109 VLPs
per gram [85]. While this is a high number of VLPs,
the ratio of viruses to bacteria in the gut lumen
(excluding the actual intestinal mucosa) is estimated
to be relatively low (0.1) when compared to other
environments, such as the ocean (5–10) [85,87]. In
contrast to luminal viral density, the actual mucosal
surfaces of the intestines are estimated to have a
very high concentration of viruses and a high
viral-to-bacteria ratio in comparison with the adjacent
environments such as the intestinal lumen and feces
[88]. The significance of the concentrated VLPs in
the mucosa is likely due to mucous–phage intricate
relationship discussed further in Viromes and
immunity below.
Human gut viromes from healthy hosts are highly
specific to individuals and fairly stable over time [75].
The stability of the gut virome was evaluated over
2.5 years during which 80% of the viral diversity was
found to persist. This longitudinal study also shed
light on the potential for rapid evolution of viruses on
human body surfaces lending some explanation to
why viromes may also be so personalized. Over the
time period sampled, a lytic phage from the family
Microviridae evolved so rapidly, it could be classified
as a new species by the end of the study [86]. In
addition to rapid evolution of lytic viruses, gut virome
composition is closely associated with both local
environment and dietary habits, as has been
found in other studies. Gut viromes of individuals
who experimentally consumed similar diets grew to
have similar viral membership, suggesting that food
could be a common reservoir from which each
individual is colonized with viruses or that certain
nutritional regimens alter an individual's gut virobiota
based on selective pressures afforded by the
nutritional milieu [75]. Interestingly, plant RNA
viruses have been found in adult gut viromes, but it
remains to be seen whether they represent stable
members of the gut virome or are present
transiently as a result of plant consumption [89].
Viruses studied in the colonization of the infant gut in
the first weeks of life, however, did not resemble
those from their diet (breast milk or formula),
suggesting that the environment is an important
initial source of viruses in infancy and likely has
some influence on formed viromes as well [90].
A study by Reyes et al. provides the most detailed
attempt to date at understanding specific dynamics
of phage host populations in the human gut [44]. In
this study, germ-free mice were given a 15-membermodel of a human gut community. The gnotobiotic
mice were then gavaged with pooled VLP extracts
from human feces and then the mice microbiomes
and viromes were monitored for changes in relative
abundances of taxa. The simultaneous addition of
diverse phage to the mouse gut did not result in a
uniform decrease in abundance in susceptible
bacteria but instead a variety of phage population
dynamics. Two phage increased in abundance
sequentially with a simultaneous drop in their
bacterial host density, followed by recovery to a
new steady state, while three other phage took
several days to replicate to reach quantifiable
abundances in the absence of any associated
change in their purported host bacterial populations.
In addition, mutations within a phage intergenic
region were observed and appeared to confer a
fitness advantage to the phage for a distinct time
during the experiment. This study is thus a simplified
model demonstrating some of the complex dynamic
equilibrium that exists among the viruses and
microbes in the gut and demonstrated that lysogenic
phage provide enriched genetic diversity to the
community which allows for varying fitness advan-
tages in different environments [44].
Oral viral ecology
The human mouth provides a diverse landscape
with bone, gums, soft palate, hard palate, and
tongue that allows for high microbial diversity and a
rich viral community [6]. Human oral viral populations
consist largely of bacteriophage, with relatively few
eukaryote viruses such as herpesviruses identified
to date. While the gastrointestinal tract has a larger
bacterial population than does the oral cavity, the
mouth has been estimated to have a higher degree
of mobile genetic elements (including viruses,
plasmids, and transposons) than are found in the
stool [91]. Many of the same trends identified in
human stool viral communities also have been found
for the oral virome, including that viral communities
are highly personalized features of individuals [6,92].
A significant proportion of human oral viruses also
are predicted to have lysogenic lifestyles, and
because the virions of lysogenic viruses are stable
components of the oral ecosystem, many oral
viruses likely live in a dynamic equilibrium with
their cellular hosts. In a recent study involving
intensive sampling of human salivary viruses, the
same viruses could be identified at all time points
over 60 days, even when they were of low relative
abundance [74]. Compared to analysis of bacterial
communities using 16S rDNA, oral viruses were
significantly more personalized in those subjects.
Despite the personalized nature of oral viruses,
both features of the human host in which the phage
resides and the human host's environment likely play
a substantial role in determining human oral viral
3897Review: Role of Viruses in Microbiomesecology. As has previously been identified for
some human bacterial communities [35,82], human
oral viruses have been significantly associated with
the sex of the human host [74], hypothesized as
possibly a response to relative hormone levels. In
the study demonstrating an association between
host sex and oral viruses, a similar association could
not be identified in the oral bacterial communities.
This may be due to limitations of the methodological
techniques for analysis of virobiota and cellular
microbiota, but as demonstrated previously, abun-
dances of phage do not necessarily correlate with
their bacterial hosts in the microbiome [6,44]. It is
also possible that analysis of viruses may be more
sensitive than bacteria for detecting differences
between human hosts.
Studies on the effect of the environment on human
oral viruses have shown that the local environment
contributes to determining membership of the oral
virome. By examining unrelated individuals from the
same households and comparing them with control
subjects from different households, it was shown
that persons sharing a living environment share a
statistically significant higher proportion of their oral
viromes compared to controls. These common
viruses could reflect a sharing of viruses via direct
personal contact or sharing through environmental
reservoirs for viruses [81]. Alternatively, this popula-
tion of shared viruses may represent similar pro-
phage among shared bacteria. Because many oral
viruses are stable members of the human oral
microbiome, the sharing of viruses between house-
hold members would have value in the potential for
genetic exchange between individuals.
Skin viral ecology
The skin is a major organ with important functions in
protection and immunity. The viral community of the
skin has been more difficult to study using metage-
nomic techniques than those of the gut or oral cavity
due to the relative dearth of sampled biomass
obtained from the skin. While there are indigenous
bacterial communities inhabiting the skin [93], many of
the identified viruses on the skin have been eukary-
otic, including papillomaviruses, circoviruses, and
polyomaviruses [94,95]. These differences in skin
virobiota compared to those of the human gut and oral
cavity may be due to the methodological differences
used to produce the viromes, where oral and gut
viromes have been enriched on density gradients and
skin viromes have been deciphered from whole skin
metagenomes including bacterial and human se-
quences. There is limited information on cutaneous
phage populations; however, the fact that many skin
bacteria haveprophage suggests that phage are likely
significant components of the cutaneous virobiota.
For example, S. aureus and Propionibacterium acnes
are normal cutaneous flora in humans, and eachcommonly has temperate phage in their genomes.
While temperate phage in S. aureus show high
diversity over time [96], phage in P. acnes have
been shown to be highly conserved even over a
30-year time span [97]. The relative lack of P. acnes
phage diversity could arise from niche specialization,
as P. acnes resides in the anaerobic follicular
environment where there likely are fewer competing
microbiota [98]. Interestingly, other cutaneous bacte-
ria including species of Streptococcus [99] and
Corynebacterium [100] have broad arrays of
CRISPRs, suggesting that they are under constant
pressure on human skin surfaces from invading
viruses.
Respiratory tract viral ecology
Resident viruses in the respiratory tract have
primarily been studied in the setting of cystic fibrosis
(CF). The respiratory tracts in CF patients generally
are heavily colonized by bacteria; thus, it is no
surprise that most of the viruses characterized in the
CF airways have been bacteriophage. Viromes of
subjects with CF have been shown to be similar in
both taxonomy and gene functions but highly
disparate from the virobiota of sputum from healthy
controls [80,101]. Phage genes sequenced from the
CF lung appear to have adapted to the diseased lung
by having increased representation of genes asso-
ciated with metabolism and anaerobic processing of
aromatic compounds that could improve their adap-
tation to biofilms and anaerobic microenvironments
in the CF lung. Additionally, there are significant
differences within the CF lung in viral ecology based
on biogeography, indicating that the complex lung
physiology impacts the local microbiota [102]. In
the diseased lung, while phage adapt to the local
environment, in healthy subjects, a significant
proportion of respiratory tract phage likely come
from the local environment. Evidence for this comes
from the significant similarities observed in phage
communities between a CF patient and her healthy
spouse [80]. The role of the environment in the lungs
is thus similar to what has been described for oral
viruses [81].
Viral communities in human blood
The human bloodstream previously had been
thought to be a sterile environment in healthy
human subjects, but virome studies have demon-
strated that they harbor substantial communities of
viruses [103]. Eukaryotic viruses including Torque
Teno viruses (TTVs) and SEN viruses among others
have been found in the healthy human bloodstream,
neither of which has been associated with patho-
genesis in humans. Interestingly, both TTV and SEN
viruses have also been identified in the human oral
cavity [6], suggesting that these viruses may have
Fig. 1. Phage are able to translocate through the mucosa into blood and local tissues where they contact the immune
system. Under this model, phage are able to disperse to virtually any body site and stimulate the adaptive immune system.
3898 Review: Role of Viruses in Microbiomestraversed mucosal surfaces en route to the human
bloodstream (Fig. 1). Analysis of the viral contents of
the blood in immunocompromised human subjects
demonstrated the relationship between immune
status and viruses, where significant immunosup-
pression resulted in altered viral ecology [104].
Again, TTVs were identified in the bloodstream of
these subjects, which coincided with their compro-
mised mucosal immunity. Some of these eukaryotic
viruses infect hematopoietic cells, while others may
enter the blood by crossing mucosa in the setting of
compromised mucosal immunity. When subjects
were treated with high doses of valganciclovir, their
herpesviruses (generally sensitive to valganciclovir)
were largely replaced by anelloviruses. Of interest, a
portion of viruses identified in the blood of these
immune suppressed and healthy patients were
phage of the order Caudovirales [103]. The fact
that phage have been identified in the bloodstream
of both healthy and immunocompromised subjects
points to blood serving as a transit for phage for
access to alternate body surfaces and demonstrates
that phage routinely can encounter the human
immune system (Fig. 1).Viral Communities Have the Capacity to
Affect Human Health and Disease
The viral ecology of the CF lung is thought to result
from the impact of the disease on the local lung
environment, where genetic predisposition results in
extreme alterations in indigenous microbial commu-
nities. Other disease states also probably have a
genetic component to their etiology but may result in
disease phenotypes driven primarily by alterations in
the host microbial ecology.Viromes and immunity
Microbiota were first observed to have a significant
role in shaping host immunity, as evidenced by the fact
that the absence of a microbiome results in an altered
immune system in germ-free mice [105]. Phage are
also proving to be a key element that helps shape
innate, humoral, and cell-mediated immunity [106].
To impact the human immune system, phage
must come in contact with the immune system and
be able to stimulate the immune system. Phage and
microbiota heavily colonize mucosal surfaces that
are border regions between the outside world and
the body that are both closely associated with
lymphoid tissue. Free bacteriophage likely access
the host immune system through translocation
across mucosal surfaces such as those in the gut
[107]. Similarly, lysogenic phage could come in
contact with the human immune system through
bacterial translocation through the mucosa and
expression of phage proteins by the bacteria or
through phage induction within host tissues. Once in
contact with the human immune system, phage are
capable of eliciting immune responses. In fact,
phage stimulation of the innate immune response
has been exploited for experimental anticancer
therapies in mice in which tumor-specific phage
activated the macrophages to secrete pro-inflam-
matory cytokines, attracting neutrophils to fight
tumor cells [108]. It is unclear, however, if phage in
their natural state on human body surfaces would
stimulate the innate immune system as such. A
disruption of the human mucosa or the immune
system, however, allows increased quantities of
phage and other viruses to gain access to the blood
and tissues, possibly eliciting immune responses
[104].
3899Review: Role of Viruses in MicrobiomesBacteriophage communities have recently been
shown to have a unique role in human immunity as a
prominent defender of the mucous barrier from
invading bacteria. The epithelial cells of mucosal
barriers continuously produce mucin glycoproteins
that are potential rich nutrients for microbiota
[88,109,110]. Mucosa have recently been shown to
be universally highly populated by phage, with a
higher phage-to-bacteria ratio than would otherwise
be expected [88]. To test whether this finding was
important for bacterial populations, a tissue culture
study was done to determine the role of lytic phage
on the mucosa. Themodel lytic phage T4 was shown
to bind to the mucus via immunoglobulin-like capsid
protein interactions with glycan residues on mucin-
ous glycoproteins. These immunoglobulin folds have
been described in bacteriophage before and have
been thought to have a role in interactions with
carbohydrates on the surface of bacterial cells [111].
As opposed to human immune system immunoglob-
ulin (Ig), phage Ig-like proteins diversify from
targeted mutations to an exposed area of
the immunoglobulin during reverse transcription
(a hypervariable region), thus allowing for adaptation
to diverse mucin glycoproteins and bacterial sur-
faces [33,111,112]. The presence of concentrated
phage bound to the mucus layer results in a dramatic
decrease in bacterial attachment to the mucus,
resulting in significantly decreased damage to tissue
culture cells [88]. This model, referred to as the
“Bacteriophage Adherence to Mucus” model, is the
first form of non-host-derived innate immunity
described in humans and may be a key part of
mucosal barrier host defenses [33].
Potential role in inflammatory bowel disease
Crohn's disease (CD) is an inflammatory disorder
of the gastrointestinal tract and is thought to be
linked to alterations in human gut ecology [3,113].
The disease has been studied as a state of dysbiosis
for bacteria, with metagenomic studies revealing
atypical and characteristic bacterial profiles in
diseased intestines [114,115]. Now virobiota are
also being examined for associations with the gut
bacterial profiles that likely promote pathogenesis.
One intriguing finding has been that there are more
VLPs associated with the gut mucosa from patients
with CD compared with controls [116], which
suggests that shifts in gut virobiota may be a feature
of CD. Additionally, there generally is lower phage
diversity in CD patients compared to healthy controls
[78]. While many viral communities such as those in
the oral cavity generally have a high number of
genotypes relatively evenly spread across the
community [6], the decrease in viral diversity in CD
likely is part of the dysbiosis that is pathognomonic of
CD. Further studies are needed to determine
whether the substantial shifts in the cellular microbialcommunities are the result of changes in the virome
or whether altered viral ecology just reflects changes
in their cellular hosts as related to another factor
such as host genotype.
Antibiotic resistance and phage
Bacteriophage are one of the major mobile genetic
elements that spread antibiotic resistance genes
among bacteria. Many potential human pathogens
have phage that carry antibiotic resistance genes,
including Streptococcus pyogenes [117], Pseudo-
monas aeruginosa [118], Salmonella enterica [119],
S. aureus [120], and Enterococcus species [121]
among others. Given their prominent role in horizon-
tal gene transfers, phage can contribute to the
success of their hosts in the microbiome through
the dissemination of antibiotic resistance genes.
Indeed, phage have been found to harbor antibiotic
resistance genes in environmental water samples
[122–125], soil [126], and even in some pre-antibiotic
era environments [127,128]. Most importantly,
phage carry antibiotic resistance in the human gut
[129,130] and oral cavity [74], forming a reservoir of
antibiotic resistance genes within the human micro-
biome [131,132]. Even if phage harboring antibiotic
resistance genes are present in non-pathogenic
bacteria, under antibiotic pressure, there is potential
for pathogenic bacteria to acquire these
phage-mediated antibiotic resistance genes [21,38].
Not only do phage communities carry antibiotic
resistance genes on human body surfaces but these
phage are also specifically induced in the setting of
antibiotic pressure. In a mouse model, exposure to
ciprofloxacin and ampicillin increased the proportion
of antibiotic resistance genes found in the phageome
of the gut [22]. While many antibiotic resistance
genes found in these phage were putatively involved
in resistance to either antibiotic, resistance to other
unrelated antibiotics also increased as a result of
antibiotic disturbances. In addition, interactions
between phage and bacteria were noted to rise in
the face of antibiotics, thus increasing the possibility
for genetic exchange. Both the functionality and the
transmissibility of phage resistance genes have
been demonstrated by exposing antibiotic-sensitive
bacteria to antibiotic-carrying phage. These sensi-
tive bacteria then become resistant to the antibiotics
themselves [22]. Thus the dynamics of phage
communities are quite relevant when considering
the emergence and stabilization of antibiotic resis-
tance in the human microbiome.
Virome involvement in human host metabolism
There is strong evidence that the human micro-
biome is closely tied to metazoan metabolism
through studies of the microbiome in conditions
such as obesity and diabetes [133–135]. The role of
3900 Review: Role of Viruses in Microbiomesviruses in host metabolism has not yet been
thoroughly studied, though several studies suggest
that they at least have an indirect role in metabolism
due to their tight relationships with their cellular
hosts. Viral communities have been shown to harbor
a host of genes putatively involved in the metabolic
functions of their hosts in aquatic ecosystems
[136,137]. However, human viral communities also
carry substantial gene functions putatively involved
in the metabolic functions of their hosts. For
example, respiratory viruses carry gene functions
involved in processing of aromatic compounds [80],
oral viruses carry gene functions involved in carbo-
hydrate and cell wall metabolism [6], and gut viruses
carry gene functions putatively involved in carbohy-
drate and amino acid metabolism [75]. The meta-
bolic genes present in a phageome can be altered
by the host environment, as demonstrated in the
adaptation of phage community metabolism to the
lungs of CF patients [80].The Role of Eukaryotic Viruses in the
Human Microbiome
Although they are not believed to represent the
majority of virus inhabitants of the human micro-
biome based on virome studies thus far, eukaryotic
viruses do have a presence among human virobiota
[106,138]. The skin is colonized by polyomaviruses
and several different human papillomaviruses that
are not believed to be associated with disease
[94,139]. The respiratory tract of healthy children has
been found to contain both picornaviruses and
coronaviruses in the absence of symptoms, even
though coronaviruses have commonly been associ-
ated with upper respiratory tract illnesses [140].
Among the bountiful phage present, the mouth also
sheds human herpesviruses [141], which are also
found in the human bloodstream [104] and are often
shed in asymptomatic individuals. The blood also
has anelloviruses in healthy individuals [142,143]
and gyroviruses whose presence is related to
immune suppression in the human host [144,145].
The gut also contains numerous eukaryotic viruses
often sequenced in studies of children with and
without diarrhea. These viruses include enterovi-
ruses [146–148], human parechoviruses [148,149],
anelloviruses [148,150], and human bocaviruses
[148,151], among others [148]. There are also
animal and plant viruses within the human gut
[89,138] such as pepper mild mottle virus, a plant
virus that has been associated with abdominal pain
and fever in humans [152].
It is unclear the extent to which eukaryotic viral
inhabitants of the human microbiome may contribute
to human health. Many of these viruses have no
known association with human disease. A recent
model regarding the role of human virobiota pro-posed is that infection with certain viruses may
provide a benefit to the human host. For example, it
has been hypothesized that the ubiquitous
skin-colonizing β-human papillomavirus persists on
human skin due to its potential to promote skin
healing [153]. Likewise, human herpesviruses may
benefit metazoans by priming the immune system for
protection against bacteria [138,154]. As virome
study methodologies improve, eukaryotic viruses
may be recognized as more prominent members of
the human virome. Thus the eukaryotic virome may
have a tightly knit evolutionary relationship to
humans, with viruses tied more closely to our genetic
fitness than we currently recognize.Limitations
While we are more advanced than the pre-omics
era in our understanding of the presence of viruses
in the microbiome, our knowledge remains limited.
Of the data collected on viruses in the microbiome,
many have used methods that might systematically
exclude certain viruses. For example, most studies
have been limited to DNA viruses, while the extent to
which RNA viruses populate human viral communi-
ties is unclear. Plant RNA viruses have been
identified in the human gut [89], yet whether their
presence is transient has not been studied. Another
example is the filtration techniques utilized to enrich
virus particles from their cellular counterparts. These
techniques necessarily exclude larger viruses that
cannot pass through 0.2-μm filters, such as the
Marseille VLPs identified in human blood or Mega-
virales that have a diameter of approximately
440 nm [155,156]. The relative lack of enveloped
viruses compared to their non-enveloped counter-
parts in some virome studies raises some concern
that methods for virome preparation are not suitable
to properly preserve all viruses. Also, the underrep-
resentation of eukaryotic viruses in these environ-
ments not only may reflect the 10:1 ratio of bacteria
to human cells but also may in part reflect an inability
of virome preparatory techniques to properly pre-
serve all viruses. Also, due to the relative lack of
available homologous sequences, the majority of
viruses in human viromes remain inadequately
described. This has been somewhat alleviated with
new bioinformatic pipelines that improve assembly
and annotate reads based on the use of multiple
expanded databases rather than just a single
database [10,75].
There are also limitations in how to approach virus
metagenome data. Most analyses of viromes are
limited to the most abundant viruses present in the
community, with little focus on viruses that may
represent a minority of available sequence reads. As
it is becoming clearer through analysis of the human
microbiome, as microbial communities are disturbed,
3901Review: Role of Viruses in Microbiomeslesser abundant microbiota can play a significant role
in repopulating the community, which may have
consequences for human health. Phage introduce
genetic diversity into their host bacteria, and when
examining these interactions on a community level,
the influx of diversitymay substantially alter the natural
history of that community. What we do not now
appreciate is whether the abundance of any individual
virus or gene function carried by that virus has a large
impact on its community and what might be the
consequences for a rise in abundance or eradication.
It may be possible that some viruses serve vital
functions within their communities and that their
eradication may be analogous to the removal of
keystone species seen in animal predator/prey
systems.Future Directions for Analysis of Human
Viromes
The virome will continue to gain importance as we
recognize its intricate role as a distinct community
within the human microbiome and its implications for
human health. Phage are likely an important
consideration for medical therapeutics. They may
be an important aspect of the etiology and possibly
treatment of inflammatory bowel disease and possi-
bly irritable bowel disorder. Phage will be an
important consideration in the era of personalized
medicine, possibly important in determining differ-
ences in pharmacokinetics. They are likely a major
contributing factor determining the efficacy of pro-
biotics, as currently administered formulations do not
generally have lasting beneficial effects on the
microbiome [157]. Probiotics capable of colonizing
the human gut that are resistant to common gut
viruses would stand a much better chance of
becoming stable members of the human gut micro-
biome. Because of their limited host range, bacteri-
ophage as antibacterial therapies in humans
became of limited appeal after the advent of
antibiotics. However, phage are becoming more
prominent contenders in medical therapies for
antibiotic resistant infections [158]. Groups of
phage are already important in the food industry as
a targeted antibacterial approach to mitigate risk for
food-borne bacterial illnesses such as listeriosis
[159]. Now that we are faced with widespread
antibiotic resistance, the relatively narrow host
range for some phage may actually prove to be an
advantage when fighting infections, as a limited host
range may result in fewer disturbances to the
indigenous microbiota of humans. Analysis of
phage as members of the human virome has greatly
added to the database of available phage genomes,
and the diversity of phage in these databases can be
harvested toward the goal of designing a better
phage. While fighting infection is one potential use ofphage, the synthesis of recombinant phage may
eventually have utility in fighting malignancies.
Because humans do not generally have significant
side effects from phage ingestions, their use in lieu of
harmful chemotherapeutics could mitigate morbidity
often incurred by conventional cancer therapies
[160].
It is clear that viruses are an enormously powerful
part of the intricate and dynamic human ecosystem.
It is enlightening to now recognize their enormous
presence on, around, and in our bodies and their
potential role in health and disease as (1) individual
viruses, (2) a collective community, and (3) as
intertwined with the human microbiome. There is
enormous potential for future work furthering our
understanding about these biologic entities that are
a dominant and established force in the ecology of
the human microbiome.
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